|
Articles that cite this website:
1. Alonso
A, Narisawa S, Bogetz J, Tautz L, Hadzic R, Huynh H, Williams S,
Gjorloff-Wingren A, Bremer MCD, Holsinger LJ, Millan JL, Mustelin T (2004). VHY,
a novel myristoylated testis-restricted dual specificity protein phosphatase
related to VHX. Journal of Biological Chemistry 279:32586-32591.
2. Alonso
A, Sasin J, Bottini N, Friedberg I, Friedberg I, Osterman A, Godzik A, Hunter
T, Dixon J, Mustelin T (2004). Protein
tyrosine phosphatases in the human genome. Cell 117:699-711.
3. Andersen
HS, Olsen OH, Iversen LF, Sorensen ALP, Mortensen SB,
Christensen MS, Branner S, Hansen TK, Lau JF, Jeppesen
L, Moran EJ, Su J, Bakir F, Judge L, Shahbaz M, Collins
T, Vo T, Newman MJ, Ripka WC, Moller NPH (2002). Discovery
and SAR of a novel selective and orally bioavailable nonpeptide
classical competitive inhibitor class of protein-tyrosine
phosphatase 1B. Journal of Medicinal Chemistry
45:4443-4459.
4. Aoki
N, Ueno S, Mano H, Yamasaki S, Shiota M, Miyazaki H, Yamaguchi-Aoki Y, Matsuda
T, Ullrich A (2004). Mutual
regulation of protein-tyrosine phosphatase 20 and protein-tyrosine kinase Tec
activities by tyrosine phosphorylation and dephosphorylation. Journal of
Biological Chemistry 279:10765-10775.
5. Bardelli
A, Velculescu VE (2005). Mutational
analysis of gene families in human cancer. Current Opinion in Genetics
& Development 15:5-12.
6. Besco
J, Popesco MC, Davuluri RV, Frostholm A, Rotter A (2004). Genomic
structure and alternative splicing of murine R2B receptor protein tyrosine
phosphatases (PTP kappa, mu, rho and PCP-2). Bmc Genomics 5:1-14.
7. Bhaduri
A, Sowdhamini R (2003). A
genome-wide survey of human tyrosine phosphatases. Protein Engineering
16:881-888.
8. Bhaduri
A, Ravishankar R, Sowdhamini R (2004). Conserved
spatially interacting motifs of protein superfamilies: Application to fold
recognition and function annotation of genome data. Proteins-Structure
Function and Bioinformatics 54:657-670.
9. Bhaduri
A, Pugalenthi G, Gupta N, Sowdhamini R (2004). iMOT:
an interactive package for the selection of spatially interacting motifs. Nucleic
Acids Research 32:W602-W605.
10. Bhaduri
A, Sowdhamini R (2005). Genome-wide
survey of prokaryotic O-protein phosphatases. Journal of Molecular
Biology 352:736-752.
11. Bialy
L, Waldmann H (2005). Inhibitors
of protein tyrosine phosphatases: Next-generation drugs? Angewandte
Chemie-International Edition 44:3814-3839.
12. Boisclair
Y, Tremblay ML (2005). Firing
up mitochondrial activities with PTPMT1. Molecular Cell 19:291-292.
13. Bretscher
A, Edwards K, Fehon RG (2002). ERM
proteins and merlin: Integrators at the cell cortex. Nature Reviews
Molecular Cell Biology 3:586-599.
14. Bukczynska
P, Klingler-Hoffmann M, Mitchelhill KI, Lam MHC, Ciccomancini
M, Tonks NK, Sarcevic B, Kemp BE, Tiganis T (2004). The
T-cell protein tyrosine phosphatase is phosphorylated
on Ser-304 by cyclin-dependent protein kinases in mitosis.
Biochemical Journal 380:939-949.
15. Cammer
SA, Hoffman BT, Speir JA, Canady MA, Nelson MR, Knutson S, Gallina M, Baxter
SM, Fetrow JS (2003). Structure-based
active site profiles for genome analysis and functional family
subclassification. Journal of
Molecular Biology 334:387-401.
16. Cardone
L, Carlucci A, Affaitati A, Livigni A, deCristofaro T, Garbi C, Varrone S,
Ullrich A, Gottesman ME, Avvedimento EV, Feliciello A (2004). Mitochondrial
AKAP121 binds and targets protein tyrosine phosphatase D1, a novel positive regulator
of src signaling. Molecular and Cellular Biology 24:4613-4626.
17. Carr
BI, Wang ZQ, Kar S (2002). K
vitamins, PTP antagonism, and cell growth arrest. Journal of Cellular
Physiology 193:263-274.
18. Chagnon
MJ, Uetani N, Tremblay ML (2004). Functional
significance of the LAR receptor protein tyrosine phosphatase
family in development and diseases. Biochemistry
and Cell Biology-Biochimie et Biologie Cellulaire
82:664-675.
19. Chang
C, Yu TW, Bargmann CI, Tessier-Lavigne M (2004). Inhibition
of netrin-mediated axon attraction by a receptor protein tyrosine phosphatase.
Science 305:103-106.
20. Changela
A, Martins A, Shuman S, Mondragon A (2005). Crystal
structure of baculovirus RNA triphosphatase complexed
with phosphate. Journal of Biological Chemistry
280:17848-17856.
21. Chauhan
S, Pandey R, Way JF, Sroka TC, Demetriou MC, Kunz S, Cress
AE, Mount DW, Miesfeld RL (2003). Androgen
regulation of the human FERM domain encoding gene EHM2
in a cell model of steroid-induced differentiation.
Biochemical and Biophysical Research Communications
310:421-432.
22. Chen
WG, Daines MO, Hershey GKK (2004). Turning
off signal transducer and activator of transcription (STAT): The negative
regulation of STAT signaling. Journal of Allergy and Clinical Immunology
114:476-489.
23. Chiarugi
P (2005). PTPs
versus PTKs: The redox side of the coin. Free Radical Research
39:353-364.
24. Chien
WW, Tidow N, Williamson EA, Shih LY, Krug U, Kettenbach A, Fermin AC, Roifman
CM, Koeffler HP (2003). Characterization
of a myeloid tyrosine phosphatase, Lyp, and its role in the Bcr-Abl signal
transduction pathway. Journal of Biological Chemistry
278:27413-27420.
25. Chin
CN, Sachs JN, Engelman DM (2005). Transmembrane
homodimerization of receptor-like protein tyrosine phosphatases. Febs
Letters 579:3855-3858.
26. Chirivi
RGS, Dilaver G, van de Vorstenbosch R, Wanschers B, Schepens J, Croes H,
Fransen J, Hendriks W (2004). Characterization
of multiple transcripts and isoforms derived from the mouse protein tyrosine
phosphatase gene Ptprr. Genes to Cells 9:919-933.
27. Chiusaroli
R, Knobler H, Luxenburg C, Sanjay A, Granot-Attas S, Tiran Z, Miyazaki T,
Harmelin A, Baron R, Elson A (2004). Tyrosine
phosphatase epsilon is a positive regulator of osteoclast function in vitro and
in vivo. Molecular Biology of the Cell 15:234-244.
28. Cismasiu
VB, Denes SA, Reilander H, Michel H, Szedlacsek SE (2004).
The
MAM (meprin/A5-protein/PTPmu) domain is a homophilic binding
site promoting the lateral dimerization of receptor-like
protein-tyrosine phosphatase mu. Journal of Biological
Chemistry 279:26922-26931.
29. Clahsen
T, Lehmann U, Stross C, Hermanns HM, Volkmer-Engert R, Schneider-Mergener J,
Heinrich PC, Schaper F (2005). The
tyrosine 974 within the LIF-R-chain of the gp130/LIF-R heteromeric receptor
complex mediates negative regulation of LIF signalling. Cellular
Signalling 17:559-569.
30. Cousin
W, Courseaux A, Ladoux A, Dani C, Peraldi P (2004). Cloning
of hOST-PTP: the only example of a protein-tyrosine-phosphatase the function of
which has been lost between rodent and human. Biochemical and
Biophysical Research Communications 321:259-265.
31. den
Hertog J, Groen A, van der Wijk T (2005). Redox
regulation of protein-tyrosine phosphatases. Archives of Biochemistry
and Biophysics 434:11-15.
32. Dewang
PM, Hsu NM, Peng SZ, Li WR (2005). Protein
tyrosine phosphatases and their inhibitors. Current Medicinal Chemistry
12:1-22.
33. Drake
PG, Peters GH, Andersen HS, Hendriks W, Moller NPH (2003). A
novel strategy for the development of selective active-site inhibitors of the
protein tyrosine phosphatase-like proteins islet-cell antigen 512 (IA-2) and
phogrin (IA-2 beta). Biochemical Journal 373:393-401.
34. Dromey
JA, Weenink SM, Peters GH, Endl J, Tighe PJ, Todd I, Christie MR (2004). Mapping
of epitopes for autoantibodies to the type 1 diabetes autoantigen IA-2 by
peptide phage display and molecular modeling: Overlap of antibody and T cell
determinants. Journal of Immunology 172:4084-4090.
35. Dube
N, Bourdeau A, Heinonen KM, Cheng A, Loy AL, Tremblay NL (2005). Genetic
ablation of protein tyrosine phosphatase 1B accelerates lymphomagenesis of
p53-null mice through the regulation of B-cell development. Cancer
Research 65:10088-10095.
36. Engelbrecht
Y, de Wet H, Horsch K, Langeveldt CR, Hough FS, Hulley
PA (2003). Glucocorticoids
induce rapid up-regulation of mitogen-activated protein
kinase phosphatase-1 and dephosphorylation of extracellular
signal-regulated kinase and impair proliferation in human
and mouse osteoblast cell lines. Endocrinology
144:412-422.
37. Ensslen-Craig
SE, Brady-Kalnay SM (2004). Receptor protein tyrosine phosphatases regulate
neural development and axon guidance. Developmental Biology 275:12-22.
38. Erdmann
KS (2003). The
protein tyrosine phosphatase PTP-Basophil/Basophil-like - Interacting proteins
and molecular functions. European Journal of Biochemistry
270:4789-4798.
39. Espagne
E, Dupuy C, Huguet E, Cattolico L, Provost B, Martins N, Poirie M, Periquet G,
Drezen JM (2004). Genome
sequence of a polydnavirus: Insights into symbiotic virus evolution. Science
306:286-289.
40. Fodero-Tavoletti
MT, Hardy MP, Cornell B, Katsis F, Sadek CM, Mitchell CA, Kemp BE, Tiganis T
(2005). Protein
tyrosine phosphatase hPTPN20a is targeted to sites of actin polymerization.
Biochemical Journal 389:343-354.
41. Forrest
ARR, Ravasi T, Taylor D, Huber T, Hume DA, Grimmond S (2003). Phosphoregulators:
Protein kinases and protein phosphatases of mouse. Genome Research
13:1443-1454.
42. Frank
C, Burkhardt C, Imhof D, Ringel J, Zschornig O, Wieligmann K, Zacharias M,
Bohmer FD (2004). Effective
dephosphorylation of Src substrates by SHP-1. Journal of Biological
Chemistry 279:11375-11383.
43. Freiss
G, Vignon F (2004). Protein
tyrosine phosphatases and breast cancer. Critical Reviews in Oncology
Hematology 52:9-17.
44. Fukada
M, Kawachi H, Fujikawa A, Noda M (2005). Yeast
substrate-trapping system for isolating substrates of protein tyrosine
phosphatases: Isolation of substrates for protein tyrosine phosphatase receptor
type z. Methods 35:54-63.
45. Fukada
T, Tonks NK (2003). Identification
of YB-1 as a regulator of PTP1B expression: implications for regulation of
insulin and cytokine signaling. Embo Journal 22:479-493.
46. Galic
S, Klingler-Hoffmann M, Fodero-Tavoletti MT, Puryer MA, Meng TC, Tonks NK,
Tiganis T (2003). Regulation
of insulin receptor signaling by the protein tyrosine phosphatase TCPTP. Molecular
and Cellular Biology 23:2096-2108.
47. Galic
S, Hauser C, Kahn BB, Haj FG, Neel BG, Tonks NK, Tiganis T (2005). Coordinated
regulation of insulin signaling by the protein tyrosine phosphatases PTP1B and
TCPTP. Molecular and Cellular Biology 25:819-829.
48. Gee
CE, Mansuy IM (2005). Protein phosphatases and their potential
implications in neuroprotective processes. Cellular and Molecular Life
Sciences 62:1120-1130.
49. Gil-Henn
H, Elson A (2003). Tyrosine
phosphatase-epsilon activates Src and supports the transformed phenotype of
Neu-induced mammary tumor cells. Journal of Biological Chemistry
278:15579-15586.
50. Goldstein
BJ, Kalyankar M, Wu XD (2005). Redox
paradox - Insulin action is facilitated by insulin-stimulated
reactive oxygen species with multiple potential signaling
targets. Diabetes 54:311-321.
51. Goldstein
BJ, Mahadev K, Wu XD, Zhu L, Motoshima H (2005). Role
of insulin-induced reactive oxygen species in the insulin
signaling pathway. Antioxidants & Redox Signaling
7:1021-1031.
52. Granot-Attas
S, Elson A (2004). Protein
tyrosine phosphatase epsilon activates Yes and Fyn in Neu-induced mammary tumor
cells. Experimental Cell Research 294:236-243.
53. Groen
A, Lemeer S, van der Wijk T, Overvoorde J, Heck AJR, Ostman A, Barford D,
Slijper M, den Hertog J (2005). Differential
oxidation of protein-tyrosine phosphatases. Journal of Biological
Chemistry 280:10298-10304.
54. Gulati
P, Markova B, Gottlicher M, Bohmer FD, Herrlich PA (2004). UVA
inactivates protein tyrosine phosphatases by calpain-mediated degradation. Embo
Reports 5:812-817.
55. Guo
F, Nguyen DT, Stuible M, Dube N, Tremblay ML, Chevet E (2004). Protein-tyrosine
phosphatase 1B potentiates IRE1 signaling during endoplasmic reticulum stress.
Journal of Biological Chemistry 279:49689-49693.
56. Guo
K, Li J, Tang JP, Koh V, Gan BQ, Zeng Q (2004). Catalytic
domain of PRL-3 plays an essential role in tumor metastasis - Formation of
PRL-3 tumors inside the blood vessels. Cancer Biology & Therapy
3:945-951.
57. Hansen
SK, Cancilla MT, Shiau TP, Kung J, Chen T, Erlanson DA (2005). Allosteric
inhibition of PTP1B activity by selective modification of a non-active site
cysteine residue. Biochemistry 44:7704-7712.
58. Hinton
SD, Yang DZ, Eckberg WR (2003). Protein
tyrosine phosphatases in Chaetopterus egg activation. Development Growth
& Differentiation 45:405-415.
59. Hoffman
BT, Nelson MR, Burdick K, Baxter SM (2004). Protein
tyrosine phosphatases: Strategies for distinguishing proteins in a family
containing multiple drug targets and anti-targets. Current
Pharmaceutical Design 10:1161-1181.
60. Hoffman
HE, Blair ER, Johndrow JE, Bishop AC (2005). Allele-specific
inhibitors of protein tyrosine phosphatases. Journal of the American
Chemical Society 127:2824-2825.
61. Hulley
P, Davison A (2003). Regulation
of tyrosine phosphorylation cascades by phosphatases: What the actions of
vanadium teach us. Journal of Trace Elements in Experimental Medicine
16:281-290.
62. Iversen
LF, Andersen HS, Moller KB, Olsen OH, Peters GH, Branner S, Mortensen SB,
Hansen TK, Lau J, Ge Y, Holsworth DD, Newman NJ, Moller NPH (2001). Steric
hindrance as a basis for structure-based design of selective inhibitors of
protein-tyrosine phosphatases. Biochemistry 40:14812-14820.
63. Iversen
LF, Moller KB, Pedersen AK, Peters GH, Petersen AS, Andersen HS, Branner S,
Mortensen SB, Moller NPH (2002). Structure
determination of T cell protein-tyrosine phosphatase. Journal of Biological
Chemistry 277:19982-19990.
64. Jacob
ST, Motiwala T (2005). Epigenetic
regulation of protein tyrosine phosphatases: potential molecular targets for
cancer therapy. Cancer Gene Therapy 12:665-672.
65. Jiao
JW, Kaur N, Lu B, Reeves SA, Halvorsen SW (2003). Initiation
and maintenance of CNTF-Jak/STAT signaling in neurons is blocked by protein
tyrosine phosphatase inhibitors. Molecular Brain Research
116:135-146.
66. Johnson
KG, Van Vactor D (2003). Receptor
protein tyrosine phosphatases in nervous system development. Physiological
Reviews 83:1-24.
67. Kappert
K, Peters KG, Bohmer FD, Ostman A (2005). Tyrosine
phosphatases in vessel wall signaling. Cardiovascular Research
65:587-598.
68. Kellie
S, Craggs G, Bird IN, Jones GE (2004). The
tyrosine phosphatase DEP-1 induces cytoskeletal rearrangements, aberrant
cell-substratum interactions and a reduction in cell proliferation. Journal
of Cell Science 117:609-618.
69. Kikuchi
K (2005). Prospect
and retrospect on protein posphatase research. Seikagaku
77:1247-1254.
70. Kim
SE, Kim SH, Choi KY (2003). Regulation
of Drosophila MKP-3 by Drosophila ERK. Apoptosis: from Signaling
Pathways to Therapeutic Tools 1010:51-61.
71. Kolkman
MJM, Streijger F, Linkels M, Bloemen M, Heeren DJ, Hendriks WJAJ, van der Zee
CEEM (2004). Mice
lacking leukocyte common antigen-related (LAR) protein tyrosine phosphatase
domains demonstrate spatial learning impairment in the two-trial water maze and
hyperactivity in multiple behavioural tests. Behavioural Brain Research
154:171-182.
72. Kraut
J, Volohonsky G, Toledano-Katchalski H, Elson A (2002). Nuclear
localization of non-receptor protein tyrosine phosphatase epsilon is regulated
by its unique N-terminal domain. Experimental Cell Research
281:182-189.
73. Larsen
M, Tremblay ML, Yamada KM (2003). Phosphatases
in cell-matrix adhesion and migration. Nature Reviews Molecular Cell
Biology 4:700-711.
74. Lehmann
U, Schmitz J, Weissenbach M, Sobota RM, Hortner M, Friederichs
K, Behrmann I, Tsiaris W, Sasaki A, Schneider-Mergener
J, Yoshimura A, Neel BG, Heinrich PC, Schaper F (2003).
SHP2
and SOCS3 contribute to Tyr-759-dependent attenuation
of interleukin-6 signaling through gp130. Journal
of Biological Chemistry 278:661-671.
75. Lund
IK, Andersen HS, Iversen LF, Olsen OH, Moller KB, Pedersen AK, Ge Y, Holsworth
DD, Newman MJ, Axe FU, Moller NPH (2004). Structure-based
design of selective and potent inhibitors of protein-tyrosine phosphatase beta.
Journal of Biological Chemistry 279:24226-24235.
76. Lund
IK, Hansen JA, Andersen HS, Moller NPH, Billestrup N (2005). Mechanism
of protein tyrosine phosphatase 1B-mediated inhibition of leptin signalling.
Journal of Molecular Endocrinology 34:339-351.
77. Markova
B, Herrlich P, Ronnstrand L, Bohmer FD (2003). Identification
of protein tyrosine phosphatases associating with the PDGF receptor. Biochemistry
42:2691-2699.
78. Martin
MC, Oliver J, Urcelay E, Orozco G, Gomez-Garcia M, Lopez-Nevot MA, Pinero A,
Brieva JA, de la Concha EG, Nieto A, Martin J (2005). The
functional genetic variation in the PTPN22 gene has a negligible effect on the
susceptibility to develop inflammatory bowel disease. Tissue Antigens
66:314-317.
79. Martins
A, Shuman S (2002). Mutational
analysis of baculovirus phosphatase identifies structural residues important
for triphosphatase activity in vitro and in vivo. Biochemistry
41:13403-13409.
80. Meng
TC, Fukada T, Tonks NK (2002). Reversible
oxidation and inactivation of protein tyrosine phosphatases in vivo. Molecular
Cell 9:387-399.
81. Meng
TC, Tonks NK (2003). Analysis
of the regulation of protein tyrosine phosphatases in vivo by reversible
oxidation. Methods Enzymol: Protein Phosphatases 366:304-318.
82. Meng
TC, Buckley DA, Galic S, Tiganis T, Tonks NK (2004). Regulation
of insulin signaling through reversible oxidation of the protein-tyrosine
phosphatases TC45 and PTP1B. Journal of Biological Chemistry
279:37716-37725.
83. Montoya
GE, Vernot JP, Patarroyo ME (2004). Comparative
analysis of CD45 proteins in primate context: owl monkeys vs humans. Tissue
Antigens 64:165-172.
84. Motiwala
T, Kutay H, Ghoshal K, Bai SM, Seimiya H, Tsuruo T, Suster S, Morrison C, Jacob
ST (2004). Protein
tyrosine phosphatase receptor-type O (PTPRO) exhibits characteristics of a
candidate tumor suppressor in human lung cancer. Proceedings of the
National Academy of Sciences of the United States of America
101:13844-13849.
85. Muller
S, Lamszus K, Nikolich K, Westphal M (2004). Receptor
protein tyrosine phosphatase zeta as a therapeutic target for glioblastoma
therapy. Expert Opinion on Therapeutic Targets 8:211-220.
86. Mustelin
T, Tautz L, Page R (2005). Structure
of the hematopoietic tyrosine phosphatase (HePTP) catalytic domain: Structure
of a KIM phosphatase with phosphate bound at the active site. Journal of
Molecular Biology 354:150-163.
87. Mustelin
T, Vang T, Bottini N (2005). Protein
tyrosine phosphatases and the immune response. Nature Reviews Immunology
5:43-57.
88. Neel
BG, Gu HH, Pao L (2003). The
'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling.
Trends in Biochemical Sciences 28:284-293.
89. Niisato
K, Fujikawa A, Komai S, Shintani T, Watanabe E, Sakaguchi G, Katsuura G, Manabe
T, Noda M (2005). Age-dependent
enhancement of hippocampal long-term potentiation and impairment of spatial
learning through the Rho-associated kinase pathway in protein tyrosine
phosphatase receptor type Z-deficient mice. Journal of Neuroscience
25:1081-1088.
90. Oganesian
A, Poot M, Daum G, Coats SA, Wright MB, Seifert RA, Bowen-Pope
DF (2003). Protein
tyrosine phosphatase RQ is a phosphatidylinositol phosphatase
that can regulate cell survival and proliferation.
Proceedings of the National Academy of Sciences of
the United States of America 100:7563-7568.
91. Orozco
G, Sanchez E, Gonzalez-Gay MA, Lopez-Nevot MA, Torres B, Caliz R,
Ortego-Centeno N, Jimenez-Alonso J, Pascual-Salcedo D, Balsa A, de Pablo R,
Nunez-Roldan A, Gonzalez-Escribano MF, Martin J (2005). Association
of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid
protein phosphatase, with rheumatoid arthritis and systemic lupus
erythematosus. Arthritis and Rheumatism 52:219-224.
92. Pagliarini
DJ, Worby CA, Dixon JE (2004). A
PTEN-like phosphatase with a novel substrate specificity.
Journal of Biological Chemistry 279:38590-38596.
93. Pagliarini
DJ, Wiley SE, Kimple ME, Dixon JR, Kelly P, Worby CA,
Casey PJ, Dixon JE (2005). Involvement
of a mitochondrial phosphatase in the regulation of ATP
production and insulin secretion in pancreatic beta cells.
Molecular Cell 19:197-207.
94. Pasquali
C, Curchod ML, Walchli S, Espanel X, Guerrier M, Arigoni F, Strous G, van
Huijsduijnen RH (2003
Identification of protein tyrosine phosphatases with specificity for the
ligand-activated growth hormone receptor. Molecular Endocrinology
17:2228-2239.
95. Paul
S, Lombroso PJ (2003). Receptor
and nonreceptor protein tyrosine phosphatases in the nervous system. Cellular
and Molecular Life Sciences 60:2465-2482.
96. Pedersen
AK, Guo XL, Moller KB, Peters GH, Andersen HS, Kastrup
JS, Mortensen SB, Iversen LF, Zhang ZY, Moller NPH (2004).
Residue
182 influences the second step of protein-tyrosine phosphatase-mediated
catalysis. Biochemical Journal 378:421-433.
97. Peisach
E, Selengut JD, Dunaway-Mariano D, Allen KN (2004). X-ray
crystal structure of the hypothetical phosphotyrosine phosphatase MDP-1 of the
haloacid dehalogenase superfamily. Biochemistry 43:12770-12779.
98. Persson
C, Engstrom U, Mowbray SL, Ostman A (2002). Primary
sequence determinants responsible for site-selective dephosphorylation of the
PDGF beta-receptor by the receptor-like protein tyrosine phosphatase DEP-1.
Febs Letters 517:27-31.
99. Persson
C, Sjoblom T, Groen A, Kappert K, Engstrom U, Hellman U, Heldin CH, den Hertog
J, Ostman A (2004). Preferential
oxidation of the second phosphatase domain of receptor-like PTP-alpha revealed
by an antibody against oxidized protein tyrosine phosphatases. Proceedings
of the National Academy of Sciences of the United States of America 101:1886-1891.
100. Persson
C, Kappert K, Engstrom U, Ostman A, Sjoblom T (2005). An
antibody-based method for monitoring in vivo oxidation of protein tyrosine
phosphatases. Methods 35:37-43.
101. Peters
GH, Iversen LF, Andersen HS, Moller NPH, Olsen OH (2004). Residue
259 in protein-tyrosine phosphatase PTPlB and PTP alpha determines the
flexibility of glutamine 262. Biochemistry 43:8418-8428.
102. Petrone
A, Battaglia F, Wang C, Dusa A, Su J, Zagzag D, Bianchi R, Casaccia-Bonnefil P,
Arancio O, Sap J (2003). Receptor
protein tyrosine phosphatase alpha is essential for hippocampal neuronal
migration and long-term potentiation. Embo Journal 22:4121-4131.
103. Pils
B, Schultz J (2004). Evolution
of the multifunctional protein tyrosine phosphatase family. Molecular Biology
and Evolution 21:625-631.
104. Poole
AW, Jones ML (2005). A
SHPing tale: Perspectives on the regulation of SHP-1 and SHP-2 tyrosine
phosphatases by the C-terminal tail. Cellular Signalling
17:1323-1332.
105. Provost
B, Varricchio P, Arana E, Espagne E, Falabella P, Huguet E, La Scaleia R,
Cattolico L, Poirie M, Malva C, Olszewski JA, Pennacchio F, Drezen JM (2004). Bracoviruses
contain a large multigene family coding for protein tyrosine phosphatases. Journal
of Virology 78:13090-13103.
106. Rebay
I, Silver SJ, Tootle TL (2005). New
vision from Eyes absent: transcription factors as enzymes. Trends in
Genetics 21:163-171.
107. Reth
M (2002). Hydrogen
peroxide as second messenger in lymphocyte activation. Nature Immunology
3:1129-1134.
108. Roskoski
R (2005). Src
kinase regulation by phosphorylation and dephosphorylation.
Biochemical and Biophysical Research Communications
331:1-14.
109. Rueda
B, Nunez C, Orozco G, Lopez-Nevot MA, de la Concha EG, Martin J, Urcelay E
(2005). C1858T
functional variant of PTPN22 gene is not associated with celiac disease genetic
predisposition. Human Immunology 66:848-852.
110. Sajnani-Perez
G, Chilton JK, Aricescu AR, Haj F, Stoker AW (2003). Isoform-specific
binding of the tyrosine phosphatase PTP sigma to a ligand in developing muscle.
Molecular and Cellular Neuroscience 22:37-48.
111. Salmeen
A, Barford D (2005). Functions
and mechanisms of redox regulation of cysteine-based phosphatases. Antioxidants
& Redox Signaling 7:560-577.
112. Salvi
M, Stringaro A, Brunati AM, Agostinelli E, Arancia G, Clari G, Toninello A
(2004). Tyrosine
phosphatase activity in mitochondria: presence of Shp-2 phosphatase in
mitochondria. Cellular and Molecular Life Sciences 61:2393-2404.
113. Scapin
G, Patel SB, Becker JW, Wang QP, Desponts C, Waddleton D, Skorey K, Cromlish W,
Bayly C, Therien M, Gauthier JY, Li CS, Lau CK, Ramachandran C, Kennedy BP, Asante-Appiah
E (2003). The
structural basis for the selectivity of benzotriazole inhibitors of PTP1B. Biochemistry
42:11451-11459.
114. Seifert
RA, Coats SA, Oganesian A, Wright MB, Dishmon M, Booth CJ, Johnson RJ, Alpers
CE, Bowen-Pope DF (2003). PTPRQ
is a novel phosphatidylinositol phosphatase that can be expressed as a
cytoplasmic protein or as a subcellularly localized receptor-like protein. Experimental
Cell Research 287:374-386.
115. Singh
NN, Androphy EJ, Singh RN (2004). The
regulation and regulatory activities of alternative splicing of the SMN gene.
Critical Reviews in Eukaryotic Gene Expression 14:271-285.
116. Stern
DF (2005). Phosphoproteomics
for oncology discovery and treatment. Expert Opinion on Therapeutic
Targets 9:851-860.
117. Stoker
A (2005). Methods
for identifying extracellular ligands of RPTPs. Methods 35:80-89.
118. Tartaglia
M, Gelb BD (2005). Germ-line
and somatic PTPN11 mutations in human disease. European Journal of
Medical Genetics 48:81-96.
119. Tiganis
T (2002). Protein
tyrosine phosphatases: Dephosphorylating the epidermal growth factor receptor.
Iubmb Life 53:3-14.
120. Tiran
Z, Peretz A, Attali B, Elson A (2003). Phosphorylation-dependent
regulation of Kv2.1 channel activity at tyrosine 124 by Src and by
protein-tyrosine phosphatase epsilon. Journal of Biological Chemistry
278:17509-17514.
121. Tobin
JF, Tam S (2002). Recent
advances in the development of small molecule inhibitors of PTP1B for the
treatment of insulin resistance and type 2 diabetes. Current Opinion in
Drug Discovery & Development 5:500-512.
122. Toledano-Katchalski
H, Tiran Z, Sines T, Shani G, Granot-Attas S, den Hertog
J, Elson A (2003). Dimerization
in vivo and inhibition of the nonreceptor form of protein
tyrosine phosphatase epsilon. Molecular and Cellular
Biology 23:5460-5471.
123.
Toledano-Katchalski H, Kraut J, Sines T, Granot-Attas
S, Shohat G, Gil-Henn H, Yung Y, Elson A (2003). Protein
tyrosine phosphatase epsilon inhibits signaling by mitogen-activated
protein kinases. Molecular Cancer Research
1:541-550.
124. Tonks
NK (2003). PTP1B: From
the sidelines to the front lines! Febs Letters 546:140-148.
125. Tootle
TL, Silver SJ, Davies EL, Newman V, Latek RR, Mills IA, Selengut JD, Parlikar
BEW, Rebay I (2003). The
transcription factor Eyes absent is a protein tyrosine phosphatase. Nature
426:299-302.
126. Touyz
RM, Tabet F, Schiffrin EL (2003). Redox-dependent
signalling by angiotensin II and vascular remodelling in hypertension. Clinical
and Experimental Pharmacology and Physiology 30:860-866.
127. Touyz
RM (2004). Reactive
oxygen species and angiotensin II signaling in vascular cells - implications in
cardiovascular disease. Brazilian Journal of Medical and Biological Research
37:1263-1273.
128. Touyz
RM (2005). Reactive
oxygen species as mediators of calcium signaling by angiotensin II: Implications
in vascular physiology and pathophysiology. Antioxidants & Redox
Signaling 7:1302-1314.
129. van
der Wijk T, Blanchetot C, Overvoorde J, den Hertog J (2003). Redox-regulated
rotational coupling of receptor protein-tyrosine phosphatase alpha dimers. Journal
of Biological Chemistry 278:13968-13974.
130. van
der Wijk T, Overvoorde J, den Hertog J (2004). H2O2-induced
intermolecular disulfide bond formation between receptor protein-tyrosine
phosphatases. Journal of Biological Chemistry 279:44355-44361.
131. van
Huijsduijnen RH, Bombrun A, Swinnen D (2002). Selecting
protein tyrosine phosphatases as drug targets. Drug Discovery Today
7:1013-1019.
132. van
Huijsduijnen RH, Sauer WHB, Bombrun A, Swinnen D (2004). Prospects
for inhibitors of protein tyrosine phosphatase 1B as antidiabetic drugs. Journal
of Medicinal Chemistry 47:4142-4146.
133. Vikman
S, Essand M, Cunningham JL, De La Torre M, Oberg K, Totterman TH, Giandomenio V
(2005). Gene
expression in midgut carcinoid tumors: Potential targets for immunotherapy.
Acta Oncologica 44:32-40.
134. Villa
F, Deak M, Bloomberg GB, Alessi DR, van Aalten DMF (2005). Crystal
structure of the PTPL1/FAP-1 human tyrosine phosphatase mutated in colorectal
cancer - Evidence for a second phosphotyrosine substrate recognition pocket.
Journal of Biological Chemistry 280:8180-8187.
135. Wabakken
T, Hauge H, Funderud S, Aasheim HC (2002). Characterization,
expression and functional aspects of a novel protein tyrosine
phosphatase epsilon isoform. Scandinavian Journal
of Immunology 56:276-285.
136. Walchli
S, Espanel X, Harrenga A, Rossi M, Cesareni G, van Huijsduijnen RH (2004). Probing
protein-tyrosine phosphatase substrate specificity using a
phosphotyrosine-containing phage library. Journal of Biological
Chemistry 279:311-318.
137. Walchli
S, Espanel X, van Huijsduijnen RH (2005). Sap-1/PTPRH
activity is regulated by reversible dimerization. Biochemical and Biophysical
Research Communications 331:497-502.
138. Wang
SE, Wu FY, Shin I, Qu SM, Arteaga CL (2005). Transforming
growth factor beta (TGF-beta)-Smad target gene protein tyrosine phosphatase
receptor type kappa is required for TGF-beta function. Molecular and
Cellular Biology 25:4703-4715.
139. Wang
ZH, Shen D, Parsons DW, Bardelli A, Sager J, Szabo S, Ptak J, Silliman N,
Peters BA, van der Heijden MS, Parmigiani G, Yan H, Wang TL, Riggins G, Powell
SM, Willson JKV, Markowitz S, Kinzler KW, Vogelstein B, Velculescu VE (2004). Mutational
analysis of the tyrosine phosphatome in colorectal cancers. Science
304:1164-1166.
140. Wansink
DG, Peters W, Schaafsma I, Sutmuller RPM, Oerlemans F, Adema GJ, Wieringa B,
van der Zee CEEM, Hendriks W (2004). Mild
impairment of motor nerve repair in mice lacking PTP-BL tyrosine phosphatase
activity. Physiological Genomics 19:50-60.
141. Welte
S, Baringhaus KH, Schmider W, Muller G, Petry S, Tennagels N (2005). 6,8-Difluoro-4-methylumbiliferyl
phosphate: a fluorogenic substrate for protein tyrosine phosphatases. Analytical
Biochemistry 338:32-38.
142. Wiesmann
C, Barr KJ, Kung J, Zhu J, Erlanson DA, Shen W, Fahr BJ,
Zhong M, Taylor L, Randal M, McDowell RS, Hansen SK (2004).
Allosteric
inhibition of protein tyrosine phosphatase 1B. Nature
Structural & Molecular Biology 11:730-737.
143. Wolstencroft
K, McEntire R, Stevens R, Tabernero L, Brass A (2005).
Constructing
ontology-driven protein family databases. Bioinformatics 21:1685-1692.
144. Wolstencroft
KJ, Stevens R, Tabernero L, Brass A (2005). PhosphaBase:
An ontology-driven database resource for protein phosphatases.
Proteins-Structure Function and Bioinformatics
58:290-294.
145. Xie
LP, Zhang YL, Zhang ZY (2002). Design
and characterization of an improved protein tyrosine phosphatase
substrate-trapping mutant. Biochemistry 41:4032-4039.
146. Zeng
Q, Dong JM, Guo K, Li J, Tan HX, Koh V, Pallen CJ, Manser E, Hong W (2003). PRL-3
and PRL-1 promote cell migration, invasion, and metastasis. Cancer
Research 63:2716-2722.
147. Zeng
WY, Wang YH, Zhang YC, Yang WL, Shi YY (2003). Functional
significance of conserved glycine 127 in a human dual-specificity protein
tyrosine phosphatase. Biochemistry-Moscow 68:634-638.
148. Zhang
ZY (2003). Mechanistic
studies on protein tyrosine phosphatases. Progress in Nucleic Acid
Research and Molecular Biology, Vol 73 73:171-220.
149. Zhao
RX, Xing S, Li Z, Fu XQ, Li QS, Krantz SB, Zhao ZHJ (2005). Identification
of an acquired JAK2 mutation in Polycythemia vera. Journal of Biological
Chemistry 280:22788-22792.
150. Zhao
ZJ, Vainchenker W, Krantz SB, Casadevall N, Constantinescu SN (2005). Role
of tyrosine kinases and phosphatases in Polycythemia vera. Seminars in
Hematology 42:221-229.
(Updated December 2005)
|
